Pfizer, Valneva partly discontinue Lyme disease vaccine trial in US
The discontinuation of US participants is due to violation of Good Clinical Practice (GCP) at certain clinical trial…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 Feb 23
The discontinuation of US participants is due to violation of Good Clinical Practice (GCP) at certain clinical trial…
15 Feb 23
The Phase 3 clinical trial, to be conducted by Fujifilm’s subsidiary Fujifilm Toyama Chemical, and the Foundation for…
02 Jan 23
The Phase 3 study has met its primary endpoint of non-inferiority and superiority in the annualised bleeding rate…
06 Dec 22
The Phase 3 trial has met the primary endpoint of radiographic progression-free survival (rPFS) in PSMA-positive mCRPC who…
28 Nov 22
The South Korean biotech firm claimed that the anticancer therapy candidate could complete chemotherapy with two doses in…
25 Nov 22
The two-dose vaccine, which leverages the same mRNA technology used in the Covid-19 vaccines developed by Pfizer and…
17 Nov 22
Zolbetuximab is an investigational monoclonal antibody that targets Claudin 18.2 and is used for the treatment of CLDN18.2-positive,…
15 Nov 22
The company will initiate a post-approval efficacy study in areas with active chikungunya virus (CHIKV) transmission, in collaboration…
01 Nov 22
The study evaluated the efficacy and safety of Reblozyl in treating anaemia due to very low-, low- or…
20 Oct 22
The FDA Emergency Use Authorisation decision was based on the findings of the phase 3 Prevent-19 clinical trial…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates